Vaishno Drugs & Intermediates Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.70 M
- Revenue Growth 20.26%
- Profit Growth 158.84%
- Ebitda -17.80%
- Net Worth 2.49%
- Total Assets -7.18%
About Vaishno Drugs & Intermediates
Vaishno Drugs & Intermediates Private Limited (VDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 2007 and has a history of 17 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Sitaravamma Bommareddy and Venkateswara Bommareddy serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2007PTC056229
-
Company No.
056229
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Nov 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Vaishno Drugs & Intermediates?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswara Bommareddy
|
Managing Director | 06-Nov-2007 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sitaravamma Bommareddy
|
Director | 06-Nov-2007 | Current |
Financial Performance of Vaishno Drugs & Intermediates.
Vaishno Drugs & Intermediates Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.26% increase. The company also saw a substantial improvement in profitability, with a 158.84% increase in profit. The company's net worth moved up by a moderate rise of 2.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaishno Drugs & Intermediates?
In 2020, Vaishno Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vrishabha Laboratories Private LimitedSitaravamma Bommareddy and Venkateswara Bommareddy are mutual person
Charges (Loans)
₹0.70 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2008 | Hdfc Bank Limited | ₹0.70 M | Open |
How Many Employees Work at Vaishno Drugs & Intermediates?
Unlock and access historical data on people associated with Vaishno Drugs & Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaishno Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaishno Drugs & Intermediates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.